BioLineRx Ltd
Modi'in-Maccabim-Re'ut, Center District, Israel · Biopharma, Biotechnology, Healthcare
BioLineRx is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The company's first approved product is APHEXDA® (motixafortide) with an indication in the U.S. for stem cell mobilization for autologous transplantation in multiple myeloma. BioLineRx is advancing a pipeline of investigational medicines for patients with sickle cell disease, p
Key facts
- Headquarters
- Modi'in-Maccabim-Re'ut, Center District, Israel
- Employees
- 28
- Industries
- Biopharma, Biotechnology, Healthcare
- Status
- Public (BLRX)
- Website
- biolinerx.com
- Company page
Recent activity at BioLineRx Ltd
- : BioLineRx Ltd
- : BioLineRx Ltd. and Hemispherian AS Form Joint Venture to Develop GLIX1 for Treating Glioblastoma. (date Fundz recorded it)
- : BioLineRx accesses second tranche of $20 million under previously announced $40 million non-dilutive debt financing agreement with BlackRock
- : BioLineRx Ltd.
- : BioLineRx Ltd.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
BioLineRx Ltd funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2026 | Venture | $3.8M |
| Apr 2024 | Pre-Seed | $20.0M |
| Jun 2020 | Venture | $9.0M |
| Jun 2020 | Pre-Seed | $4.4M |
Leadership
- Aharon Schwartz, Director
- Michael Anghel, Director
- Nurit Benjamini, Director
- Barbara Bormann, Director
- Raphael Hofstein, Director
- Avraham Molcho, Director
- Sandra Panem, Director
Verified email and direct lines for BioLineRx Ltd’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
BioLineRx Ltd in the news
- BioLineRx to Report Second Quarter 2026 Results on August 31, 2026 - Morningstar (Aug 25, 2026)
- BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education Day - PR Newswire (Oct 08, 2026)
- BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD) - Finansavisen (May 30, 2024)
- BioLineRx and Hemispherian Present Preclinical Data Demonstrating Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancer at ESMO 2026 - PR Newswire (Oct 23, 2026)
- BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd. - Finansavisen (Nov 21, 2024)
Companies similar to BioLineRx Ltd
- Tempest Therapeutics · Biopharma, Biotechnology, Healthcare, Health Care, Therapeutics
- Cantargia AB · Biopharma, Biotechnology, Health Care, research, Therapeutics
- Retension Pharmaceuticals · Biopharma, Biotechnology, Healthcare, Health Care, Therapeutics
- Aarvik Therapeutics · Biotechnology, Healthcare, Health Care, research, Therapeutics
- Takis S.r.l · Biopharma, Biotechnology, Health Care, research, Therapeutics
About BioLineRx Ltd: questions and answers
What does BioLineRx Ltd do?
BioLineRx is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The company's first approved product is APHEXDA® (motixafortide) with an indication in the U.S. for stem cell mobilization for autologous transplantation in multiple myeloma. BioLineRx is advancing a pipeline of investigational medicines for patients with sickle cell disease, p
Where is BioLineRx Ltd headquartered?
BioLineRx Ltd is headquartered in Modi'in-Maccabim-Re'ut, Center District, Israel.
How many employees does BioLineRx Ltd have?
BioLineRx Ltd has about 28 employees.
Has BioLineRx Ltd raised funding?
Yes. Fundz has recorded 4 funding events for BioLineRx Ltd. The most recent, $3.8M, was in Aug 2026.
What is the latest news on BioLineRx Ltd?
On Aug 27, 2026, BioLineRx Ltd
Is BioLineRx Ltd a public company?
Yes. BioLineRx Ltd is publicly traded under the ticker BLRX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy